Andreoli C, Buranelli F, Campa T, Costa A, Magni A, Pizzichetta M, Ciatto S
Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italia.
Tumori. 1987 Oct 31;73(5):463-5. doi: 10.1177/030089168707300506.
The authors report on 83 cases of intrathoracic metastases (ITM) observed as isolated first recurrences in a ten-year experience of periodic chest x-ray (CXR) survey of primary breast cancer. In 44 of 83 cases ITM were detected on CXR in absence of subjective symptoms or clinical signs (A) whereas 39 ITM cases were detected as subjectively (S) symptomatic in the interval between two planned CXR controls. Diagnosis was anticipated by CXR survey as the disease-free interval was significantly shorter (30 vs. 43 months, p less than 0.04) for A respect to S cases. Nevertheless such a diagnostic anticipation had no prognostic impact as the ten year survival from primary treatment did not differ (0.12 vs. 0.16, p = 0.6) between A and S cases. Multivariate analysis confirmed that no impact on survival from primary treatment is expected whether ITM are detected in an earlier (asymptomatic, preclinical) or in a more advanced (subjectively symptomatic) phase. CXR survey after primary treatment of breast cancer seems thus a very questionable policy.
作者报告了在对原发性乳腺癌进行为期十年的定期胸部X线(CXR)检查中观察到的83例胸内转移(ITM)病例,这些病例均为首次出现的孤立复发。在83例病例中,44例ITM是在没有主观症状或临床体征的情况下通过CXR检测到的(A组),而39例ITM病例是在两次计划的CXR检查间隔期间出现主观症状(S组)时被检测到的。由于A组病例的无病生存期明显短于S组(30个月对43个月,p<0.04),CXR检查提前做出了诊断。然而,这种诊断提前对预后并无影响,因为A组和S组从初次治疗开始的十年生存率并无差异(0.12对0.16,p = 0.6)。多变量分析证实,无论ITM是在早期(无症状,临床前期)还是更晚期(有主观症状)阶段被检测到,对初次治疗的生存率均无影响。因此,乳腺癌初次治疗后的CXR检查似乎是一项很值得怀疑的策略。